Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Prior Azacitidine and Ongoing Transfusion Dependence in MDS Patients Are Associated with Inferior Survival after Allogeneic Stem Cell Transplant

Miles Horton, Becky Leung, Ricky Nelles, Matthew Rubic, Christopher McKinnely, Alia Cibich, Mark R Dowling, Stewart Hunt, Lynette C.Y. Chee, Ashleigh P Scott, David S. Ritchie, Devendra Hiwase, Duncan Purtill, Abir Bhattacharya, Glen A Kennedy, Ashish Bajel

Blood (2024) 144 (Supplement 1): 7440.

https://doi.org/10.1182/blood-2024-209705

Published: 2024

Journal Articles

CAR-T Cell Therapy in Advanced Myeloma with Extramedullary Disease - an In Vivo Imaging and Molecular Monitoring Study (CARAMEL): First Results of Cu-64 Radiolabelled Nanoparticle PET-CT and PET-MRI

Blood (2024) 144 (Supplement 1): 1029.

https://doi.org/10.1182/blood-2024-210017

Published: 2024

Journal Articles

DNA Damage Repair Pathway Variants Are Frequent in Patients Undergoing CAR-T Cell Therapy for Lymphoma and Associated with Increased Risk of Myeloid Neoplasia Post Cytotoxic Therapy

Zhi Han Yeoh, Ing Soo Tiong, Mark R Dowling, Hamish W Scott, Nicole O'Leary, Samantha van der Linde, Tamia Nguyen, Simon J Harrison, Ashish Bajel, Andrew H Wei, Piers Blombery

Blood (2024) 144 (Supplement 1): 653.

https://doi.org/10.1182/blood-2024-204494

Published: 2024

Journal Articles

Direct Visualisation of BCMA Bispecific Antibody and the Myeloma Immune Microenvironment

Jeremy Er, Rimes Joel, Light Amanda, Mark R Dowling, Simon J Harrison, Edwin Hawkins

Blood (2024) 144 (Supplement 1): 355.

https://doi.org/10.1182/blood-2024-198851

Published: 2024

Journal Articles

Predicting Risk of Infection in Patients Receiving CAR-T for Aggressive Lymphoma: A Study Exploring the Utility of Immune Profiling

Gemma K Reynolds, Lewis Williams, Mary Ann Anderson, Mark R Dowling, Adrian Minson, Michael J. Dickinson, Karin A Thursky, Simon J Harrison, Monica A Slavin, Marcel Doerflinger, Benjamin W Teh

Blood (2024) 144 (Supplement 1): 7136.

https://doi.org/10.1182/blood-2024-203133

Published: 2024

Journal Articles

Longitudinal Cytokine Expression in Aggressive Lymphoma Patients Treated with CAR-T: Applications of Immune Profiling to CAR-T

Gemma K Reynolds, Lewis Williams, Mary Ann Anderson, Mark R Dowling, Adrian Minson, Michael J. Dickinson, Karin A Thursky, Simon J Harrison, Monica A Slavin, Marcel Doerflinger, Benjamin W Teh

Blood (2024) 144 (Supplement 1): 7135.

https://doi.org/10.1182/blood-2024-202836

Published: 2024

Journal Articles

Cognitive and Psychological Recovery from the Immune Effector Cell Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Valeriya Kuznetsova, Harsh Oza, Hannah Rosenfeld, Carmela Sales, Sam van der Linde, Izanne Roos, Stefanie Roberts, Fiore D'Aprano, Samantha M. Loi, Mark R Dowling, Michael J. Dickinson, Tomas Kalincik, Simon J Harrison, Charles B. Malpas, Mary Ann Anderson

Blood (2024) 144 (Supplement 1): 7240.

https://doi.org/10.1182/blood-2024-202851

Published: 2024

Journal Articles

Real-World Patterns of Care and Outcomes for Non-Favourable Risk Acute Myeloid Leukemia Treated with Intensive Chemotherapy across Australia and New Zealand- Data Linkage between the ALLG National Blood Cancer Registry (NBCR) and the Australia and New Zealand Transplant and Cellular Therapy (ANZTCT) Registry

Blood (2024) 144 (Supplement 1): 3799.

https://doi.org/10.1182/blood-2024-209389

Published: 2024

Journal Articles

A Multi-Center Retrospective Study on Complex Karyotype in Patients with Richter Transformation Who Received No Chemoimmunotherapy for Their CLL

Blood (2024) 144 (Supplement 1): 3245.

https://doi.org/10.1182/blood-2024-205668

Published: 2024

Journal Articles

Bridging Radiotherapy to Axicabtagene Ciloleucel (axi-cel) Is Associated with Favourable Outcomes for Large B-Cell Lymphoma (LBCL) in Third-Line and Beyond: An Australian Single-Centre Real-World Experience

Hamish W Scott, Mark R Dowling, Daniel Garcia, Samantha van der Linde, Nicole O'Leary, Brydon Panozzo, Adrian Minson, James A Kuzich, Aaron Jun Ning Wong, Michael S Hofman, Monique Youl, Belinda Campbell, Michael Patrick Macmanus, Philip A. Thompson, Mary Ann Anderson, John F. Seymour, Michael J Dickinson, Simon J Harrison

Blood (2024) 144 (Supplement 1): 4511.

https://doi.org/10.1182/blood-2024-209767

Published: 2024

Journal Articles

Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter's Transformation: An International Multicenter Retrospective Study

Blood (2023) 142 (Supplement 1): 108.

https://doi.org/10.1182/blood-2023-180858

Published: 2023

Journal Articles

Outcomes of Patients with Richter Transformation without Prior Chemoimmunotherapy for CLL/SLL: An International Multicenter Retrospective Study

Blood (2023) 142 (Supplement 1): 497.

https://doi.org/10.1182/blood-2023-182114

Published: 2023

Journal Articles

Clinical Utility of Circulating Tumor (ct)DNA Quantity and Kinetics in Patients Undergoing CAR T-Cell Therapy for Relapsed/Refractory Aggressive B-Cell Lymphoma

Imogen Caldwell, Yan Zhuang Yap, Mark R Dowling, Javad Saghebi, Aaron Jun Ning Wong, Roxane Legaie, Rainier Arnolda, Clarissa Wilson, Danielle Ignacio, Nicole O'Leary, Stephanie Yaung, Bowdoin Su, Corinna Woestmann, Michael Dickinson, Ella Thompson, Piers Blombery

Blood (2023) 142 (Supplement 1): 7160.

https://doi.org/10.1182/blood-2023-182999

Published: 2023

Journal Articles

Utility of High-Throughput Sequencing of Immunoglobulin Genes for MRD in Lymphoid Malignancy in the Context of Current Immunotherapeutics

Imogen R Caldwell, Michael Ingbritsen, Yan Zhuang Yap, Mark R Dowling, Ing S Tiong, David A Westerman, Piers Blombery

Blood (2022) 140 (Supplement 1): 10731–10732.

https://doi.org/10.1182/blood-2022-162228

Published: 2022

Journal Articles

Long-Term Follow-up and Single-Cell Multiomics Characteristics of Infusion Products in Patients with Chronic Lymphocytic Leukemia Treated with CD19 CAR-T Cells

Alexandre V. Hirayama, Ye Zheng, Mark R. Dowling, Alyssa Sheih, Tinh-Doan Phi, Delaney R. Kirchmeier, Abby W. Chucka, Jordan Gauthier, David G. Maloney, Raphael Gottardo, Cameron J. Turtle

Blood (2021) 138 (Supplement 1): 1749.

https://doi.org/10.1182/blood-2021-151571

Published: 2021

Journal Articles

Risk Factors and Impact of Neurological Complications after Allogeneic Hematopoietic Stem Cell Transplantation

Mark R. Dowling, MBBS, PhD, Shuli Li, Ashmeet Bhatia, MD, Areej El-Jawahri, MD, Bimal R. Dey, MD PhD, Steven L. McAfee, MD, Hanno Hock, MD PhD, Thomas R. Spitzer, MD, Yi-Bin Chen, MD, Karen K. Ballen, MD

Blood (2016) 128 (22): 5742.

https://doi.org/10.1182/blood.V128.22.5742.5742

Published: 2016

Journal Articles

Regulation of Platelet Lifespan in the Presence and Absence of TPO Signaling

Marion Lebois, Mark R. Dowling, Philip D. Hodgkin, Benjamin T. Kile, Warren S. Alexander, Emma C. Josefsson

Blood (2015) 126 (23): 11.

https://doi.org/10.1182/blood.V126.23.11.11

Published: 2015

Journal Articles

Megakaryocytes Possess a Functional Intrinsic Apoptosis Pathway That Must Be Restrained In Order to Survive and Produce Platelets

Emma C Josefsson, Chloé James, Katya J Henley, Marlyse A Debrincat, Kelly L Rogers, Mark R Dowling, Michael J White, Elizabeth A Kruse, Sarah Ellis, Paquita Nurden, Cassandra J Vandenberg, Kylie D Mason, A O'Reilly Lorraine, Donald Metcalf, Andrew W Roberts, David CS Huang, Benjamin T Kile

Blood (2010) 116 (21): 550.

https://doi.org/10.1182/blood.V116.21.550.550

Published: 2010

Journal Articles

Platelet senescence is regulated by an internal timer, not damage inflicted by hits

Mark R. Dowling, Emma C. Josefsson, Katya J. Henley, Philip D. Hodgkin, Benjamin T. Kile

Blood (2010) 116 (10): 1776–1778.

https://doi.org/10.1182/blood-2009-12-259663

Published: 2010

Includes: Supplemental data

NARROW

Prior Azacitidine and Ongoing Transfusion Dependence in MDS Patients Are Associated with Inferior Survival after Allogeneic Stem Cell Transplant

CAR-T Cell Therapy in Advanced Myeloma with Extramedullary Disease - an In Vivo Imaging and Molecular Monitoring Study (CARAMEL): First Results of Cu-64 Radiolabelled Nanoparticle PET-CT and PET-MRI

DNA Damage Repair Pathway Variants Are Frequent in Patients Undergoing CAR-T Cell Therapy for Lymphoma and Associated with Increased Risk of Myeloid Neoplasia Post Cytotoxic Therapy

Direct Visualisation of BCMA Bispecific Antibody and the Myeloma Immune Microenvironment

Predicting Risk of Infection in Patients Receiving CAR-T for Aggressive Lymphoma: A Study Exploring the Utility of Immune Profiling

Longitudinal Cytokine Expression in Aggressive Lymphoma Patients Treated with CAR-T: Applications of Immune Profiling to CAR-T

Cognitive and Psychological Recovery from the Immune Effector Cell Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

A Multi-Center Retrospective Study on Complex Karyotype in Patients with Richter Transformation Who Received No Chemoimmunotherapy for Their CLL

Bridging Radiotherapy to Axicabtagene Ciloleucel (axi-cel) Is Associated with Favourable Outcomes for Large B-Cell Lymphoma (LBCL) in Third-Line and Beyond: An Australian Single-Centre Real-World Experience

Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter's Transformation: An International Multicenter Retrospective Study

Outcomes of Patients with Richter Transformation without Prior Chemoimmunotherapy for CLL/SLL: An International Multicenter Retrospective Study

Clinical Utility of Circulating Tumor (ct)DNA Quantity and Kinetics in Patients Undergoing CAR T-Cell Therapy for Relapsed/Refractory Aggressive B-Cell Lymphoma

Utility of High-Throughput Sequencing of Immunoglobulin Genes for MRD in Lymphoid Malignancy in the Context of Current Immunotherapeutics

Long-Term Follow-up and Single-Cell Multiomics Characteristics of Infusion Products in Patients with Chronic Lymphocytic Leukemia Treated with CD19 CAR-T Cells

Risk Factors and Impact of Neurological Complications after Allogeneic Hematopoietic Stem Cell Transplantation

Regulation of Platelet Lifespan in the Presence and Absence of TPO Signaling

Megakaryocytes Possess a Functional Intrinsic Apoptosis Pathway That Must Be Restrained In Order to Survive and Produce Platelets

Platelet senescence is regulated by an internal timer, not damage inflicted by hits

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only